サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1671997

動物幹細胞治療の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）

Animal Stem Cell Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 182 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
動物幹細胞治療の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）
出版日: 2025年02月24日
発行: Persistence Market Research
ページ情報: 英文 182 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の動物幹細胞治療の市場規模は、2025年に3億610万米ドルになるとみられ、2025年～2032年の予測期間に5.2%のCAGRで拡大し、2032年には4億3,730万米ドルに達すると予測されています。

動物幹細胞治療は、幹細胞を利用して損傷した組織を修復し、変形性関節症、腱損傷、靭帯損傷、炎症性疾患など、動物の様々な病状を治療する革新的な治療法です。この治療法では主に、骨髄、脂肪組織、臍帯血由来の間葉系幹細胞（MSC）が使用されます。動物幹細胞治療市場は、高度な再生治療の選択肢を求める動物病院、研究機関、ペットの飼い主を対象としています。市場成長の原動力となっているのは、ペットの飼育数の増加、再生治療に対する意識の高まり、治療成績や利用しやすさを向上させる獣医療の進歩などです。

世界の動物幹細胞治療市場は、コンパニオンアニマルの整形外科疾患の有病率の上昇や、非侵襲的な治療ソリューションに対する需要の高まりなど、いくつかの主要な要因によって推進されています。高度な獣医学的治療や幹細胞治療の利点に対する飼い主の意識の高まりが、市場拡大のさらなる原動力となっています。幹細胞の分離技術や凍結保存技術の向上といった技術的進歩は、治療効果を高め、幹細胞の応用範囲を拡大します。加えて、獣医学的再生医療への投資の増加や、バイオテクノロジー企業と獣医学研究機関との共同研究も、市場の急速な開拓に寄与しています。

動物幹細胞治療市場は、再生医療の継続的研究、動物医療費の増加、個別化治療アプローチの市場開拓によって、大きな成長機会をもたらしています。幹細胞治療とAIを活用した診断や遠隔医療などのデジタルヘルス技術の融合は、治療モニタリングや患者の予後を向上させます。加えて、自己免疫疾患、神経疾患、創傷治癒など、幹細胞治療の応用範囲は筋骨格疾患以外にも広がっており、市場関係者に新たな収益源を創出しています。戦略的パートナーシップ、研究開発への投資、費用対効果の高い幹細胞治療の導入は、新たな機会を捉え、進化する動物用ヘルスケア市場においてリーダーシップを維持するために不可欠です。

当レポートでは、世界の動物幹細胞治療市場について調査し、製品タイプ別、由来別、用途別、種別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲と定義
  • 市場力学
  • マクロ経済要因
  • COVID-19の影響分析
  • 予測要因- 関連性と影響

第3章 付加価値の洞察

第4章 世界の動物幹細胞治療市場の見通し

  • 主なハイライト
  • 市場規模分析と予測
  • 世界の動物幹細胞治療市場の見通し：製品タイプ別
  • 世界の動物幹細胞治療市場の見通し：由来別
  • 世界の動物幹細胞治療市場の見通し：用途別
  • 世界の動物幹細胞治療市場の見通し：種別
  • 世界の動物幹細胞治療市場の見通し：エンドユーザー別

第5章 世界の動物幹細胞治療市場の見通し：地域別

  • 主なハイライト
  • 過去の市場規模の分析、地域別、2019年～2024年
  • 現在の市場規模の分析と予測、地域別、2025年～2032年
  • 市場の魅力分析：地域別

第6章 北米の動物幹細胞治療市場の見通し

第7章 欧州の動物幹細胞治療市場の見通し

第8章 東アジアの動物幹細胞治療市場の見通し

第9章 南アジアおよびオセアニアの動物幹細胞治療市場の見通し

第10章 ラテンアメリカの動物幹細胞治療市場の見通し

第11章 中東・アフリカの動物幹細胞治療市場の見通し

第12章 競合情勢

  • 市場シェア分析、2025年
  • 市場構造
  • 企業プロファイル（詳細- 概要、財務、戦略、最近の動向）
    • Aratana Therapeutics, Inc.
    • VetStem, Inc.
    • Magellan Stem Cells
    • StemcellX
    • Boehringer Ingelheim（Global stem cell technology）
    • Cell Therapy Sciences
    • VETherapy Corporation
    • MediVet Biologics LLC（Ardent Animal Health）
    • Medrego
    • AniCell Biotech
    • Gallant
    • Companion Animal Health
    • Kintaro Cells Power
    • StemBioSys
    • Regen BioPharma, Inc.
    • Celltex Therapeutics Corporation
    • Regenexx

第13章 付録

目次
Product Code: PMRREP14941

Persistence Market Research has recently released a comprehensive report on the worldwide market for animal stem cell therapy. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global animal stem cell therapy market from 2025 to 2032.

Key Insights:

  • Animal Stem Cell Therapy Market Size (2025E): US$ 306.1 Mn
  • Projected Market Value (2032F): US$ 437.3 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.2%

Animal Stem Cell Therapy Market - Report Scope:

Animal stem cell therapy is an innovative treatment approach that utilizes stem cells to repair damaged tissues and treat various medical conditions in animals, including osteoarthritis, tendon injuries, ligament damage, and inflammatory diseases. The therapy primarily involves the use of mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue, or umbilical cord blood. The animal stem cell therapy market caters to veterinary clinics, research institutes, and pet owners seeking advanced regenerative treatment options. Market growth is driven by increasing pet adoption, rising awareness of regenerative therapies, and advancements in veterinary medicine enhancing treatment outcomes and accessibility.

Market Growth Drivers:

The global animal stem cell therapy market is propelled by several key factors, including the rising prevalence of orthopedic conditions in companion animals and the increasing demand for non-invasive treatment solutions. The growing awareness among pet owners regarding advanced veterinary care and the benefits of stem cell therapy further drive market expansion. Technological advancements, such as improved stem cell isolation and cryopreservation techniques, enhance treatment efficacy and expand the scope of stem cell applications. Additionally, increasing investments in veterinary regenerative medicine and research collaborations between biotech companies and veterinary institutions contribute to the market's rapid development.

Market Restraints:

Despite promising growth prospects, the animal stem cell therapy market faces challenges related to regulatory compliance, high treatment costs, and limited awareness in emerging markets. Stringent regulations governing stem cell therapies in veterinary applications impose compliance burdens on manufacturers and veterinary practitioners, affecting market penetration. Furthermore, the high cost of stem cell therapy, coupled with the lack of standardized protocols and reimbursement policies, limits accessibility for pet owners. Ethical concerns and the need for extensive clinical validation further pose barriers to market expansion, necessitating ongoing research and regulatory advancements.

Market Opportunities:

The animal stem cell therapy market presents significant growth opportunities driven by continuous research in regenerative medicine, increasing veterinary healthcare expenditure, and the development of personalized treatment approaches. The integration of stem cell therapy with digital health technologies, such as AI-driven diagnostics and telemedicine, enhances treatment monitoring and patient outcomes. Additionally, the expanding applications of stem cell therapy beyond musculoskeletal conditions, including autoimmune diseases, neurological disorders, and wound healing, create new revenue streams for market players. Strategic partnerships, investments in R&D, and the introduction of cost-effective stem cell therapies are essential to capitalize on emerging opportunities and sustain market leadership in the evolving veterinary healthcare landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the animal stem cell therapy market globally?
  • Which stem cell types and applications are driving the adoption of stem cell therapy in veterinary medicine?
  • How are technological advancements reshaping the competitive landscape of the animal stem cell therapy market?
  • Who are the key players contributing to the animal stem cell therapy market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global animal stem cell therapy market?

Competitive Intelligence and Business Strategy:

Leading players in the global animal stem cell therapy market, including VetStem Biopharma, Aratana Therapeutics, and Medrego, focus on innovation, clinical research, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced stem cell therapies, improve cell processing techniques, and expand the clinical applications of regenerative medicine in veterinary healthcare. Collaborations with veterinary clinics, research institutions, and biotech firms facilitate market access and promote technology adoption. Moreover, emphasis on clinical validation, patient education, and regulatory approvals fosters market growth and enhances treatment outcomes in the rapidly evolving veterinary regenerative medicine sector.

Key Companies Profiled:

  • VetStem Biopharma
  • Aratana Therapeutics
  • Medrego
  • Cell Therapy Sciences
  • Vetbiologics
  • Magellan Stem Cells
  • Stemcell Vet UK
  • Regeneus Ltd.
  • Vetherapy
  • Animal Cell Therapies, Inc.

Animal Stem Cell Therapy Market Segmentation

By Product Type

  • Hemopoietic Stem Cells
  • Mesenchymal Stem Cells

By Source

  • Allogeneic Animal Stem Cell Therapy
  • Autologous Animal Stem Cell Therapy

By Application

  • Osteoarthritis
  • Soft Tissue Injuries
  • Traumatic Fractures
  • Tendonitis
  • Inflammatory Bowel Disease

By Species

  • Canine
  • Feline
  • Equine

By End User

  • Veterinary Hospitals
  • Veterinary Clinics
  • Veterinary Research Institutes

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Animal Stem Cell Therapy Market Outlook
  • 1.2. Global Animal Stem Cell Therapy Market Outlook: Services
  • 1.3. Introduction/Key Findings
  • 1.4. Historical Market Size (US$ Mn) and Analysis, By Services, 2019-2024
  • 1.5. Current Market Size (US$ Mn) and Analysis and Forecast, By Services, 2025-2032
  • 1.6. Key Market Trends
  • 1.7. Future Market Projections
  • 1.8. Premium Market Insights
  • 1.9. Industry Developments and Key Market Events
  • 1.10. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Product Adoption Analysis
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Global Animal Stem Cell Therapy Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Animal Stem Cell Therapy Market Outlook: Product Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Product Type, 2019-2024
    • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
      • 4.3.3.1. Hemopoietic Stem Cells
      • 4.3.3.2. Mesenchymal Stem Cells
    • 4.3.4. Market Attractiveness Analysis: Product Type
  • 4.4. Global Animal Stem Cell Therapy Market Outlook: Source
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Source, 2019-2024
    • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2025-2032
      • 4.4.3.1. Allogeneic Animal Stem Cell Therapy
      • 4.4.3.2. Autologous Animal Stem Cell Therapy
    • 4.4.4. Market Attractiveness Analysis: Source
  • 4.5. Global Animal Stem Cell Therapy Market Outlook: Application
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
    • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      • 4.5.3.1. Osteoarthritis
      • 4.5.3.2. Soft Tissue Injuries
      • 4.5.3.3. Traumatic Fractures
      • 4.5.3.4. Tendonitis
      • 4.5.3.5. Inflammatory Bowel Disease
      • 4.5.3.6. Others
    • 4.5.4. Market Attractiveness Analysis: Application
  • 4.6. Global Animal Stem Cell Therapy Market Outlook: Species
    • 4.6.1. Introduction / Key Findings
    • 4.6.2. Historical Market Size (US$ Mn) Analysis, By Species, 2019-2024
    • 4.6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Species, 2025-2032
      • 4.6.3.1. Canine
      • 4.6.3.2. Feline
      • 4.6.3.3. Equine
    • 4.6.4. Market Attractiveness Analysis: Species
  • 4.7. Global Animal Stem Cell Therapy Market Outlook: End User
    • 4.7.1. Introduction / Key Findings
    • 4.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 4.7.3.1. Veterinary Hospitals
      • 4.7.3.2. Veterinary Clinics
      • 4.7.3.3. Veterinary Research Institutes
    • 4.7.4. Market Attractiveness Analysis: End User

5. Global Animal Stem Cell Therapy Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Animal Stem Cell Therapy Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Product Type
    • 6.2.3. By Source
    • 6.2.4. By Application
    • 6.2.5. By Species
    • 6.2.6. By End User
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 6.4.1. Hemopoietic Stem Cells
    • 6.4.2. Mesenchymal Stem Cells
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2025-2032
    • 6.5.1. Allogeneic Animal Stem Cell Therapy
    • 6.5.2. Autologous Animal Stem Cell Therapy
  • 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 6.6.1. Osteoarthritis
    • 6.6.2. Soft Tissue Injuries
    • 6.6.3. Traumatic Fractures
    • 6.6.4. Tendonitis
    • 6.6.5. Inflammatory Bowel Disease
    • 6.6.6. Others
  • 6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 6.7.1. Canine
    • 6.7.2. Feline
    • 6.7.3. Equine
  • 6.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 6.8.1. Veterinary Hospitals
    • 6.8.2. Veterinary Clinics
    • 6.8.3. Veterinary Research Institutes
  • 6.9. Market Attractiveness Analysis

7. Europe Animal Stem Cell Therapy Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product Type
    • 7.2.3. By Source
    • 7.2.4. By Application
    • 7.2.5. By Species
    • 7.2.6. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 7.4.1. Hemopoietic Stem Cells
    • 7.4.2. Mesenchymal Stem Cells
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2025-2032
    • 7.5.1. Allogeneic Animal Stem Cell Therapy
    • 7.5.2. Autologous Animal Stem Cell Therapy
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 7.6.1. Osteoarthritis
    • 7.6.2. Soft Tissue Injuries
    • 7.6.3. Traumatic Fractures
    • 7.6.4. Tendonitis
    • 7.6.5. Inflammatory Bowel Disease
    • 7.6.6. Others
  • 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 7.7.1. Canine
    • 7.7.2. Feline
    • 7.7.3. Equine
  • 7.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.8.1. Veterinary Hospitals
    • 7.8.2. Veterinary Clinics
    • 7.8.3. Veterinary Research Institutes
  • 7.9. Market Attractiveness Analysis

8. East Asia Animal Stem Cell Therapy Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product Type
    • 8.2.3. By Source
    • 8.2.4. By Application
    • 8.2.5. By Species
    • 8.2.6. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 8.4.1. Hemopoietic Stem Cells
    • 8.4.2. Mesenchymal Stem Cells
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2025-2032
    • 8.5.1. Allogeneic Animal Stem Cell Therapy
    • 8.5.2. Autologous Animal Stem Cell Therapy
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 8.6.1. Osteoarthritis
    • 8.6.2. Soft Tissue Injuries
    • 8.6.3. Traumatic Fractures
    • 8.6.4. Tendonitis
    • 8.6.5. Inflammatory Bowel Disease
    • 8.6.6. Others
  • 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 8.7.1. Canine
    • 8.7.2. Feline
    • 8.7.3. Equine
  • 8.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.8.1. Veterinary Hospitals
    • 8.8.2. Veterinary Clinics
    • 8.8.3. Veterinary Research Institutes
  • 8.9. Market Attractiveness Analysis

9. South Asia & Oceania Animal Stem Cell Therapy Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product Type
    • 9.2.3. By Source
    • 9.2.4. By Application
    • 9.2.5. By Species
    • 9.2.6. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 9.4.1. Hemopoietic Stem Cells
    • 9.4.2. Mesenchymal Stem Cells
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2025-2032
    • 9.5.1. Allogeneic Animal Stem Cell Therapy
    • 9.5.2. Autologous Animal Stem Cell Therapy
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 9.6.1. Osteoarthritis
    • 9.6.2. Soft Tissue Injuries
    • 9.6.3. Traumatic Fractures
    • 9.6.4. Tendonitis
    • 9.6.5. Inflammatory Bowel Disease
    • 9.6.6. Others
  • 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 9.7.1. Canine
    • 9.7.2. Feline
    • 9.7.3. Equine
  • 9.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.8.1. Veterinary Hospitals
    • 9.8.2. Veterinary Clinics
    • 9.8.3. Veterinary Research Institutes
  • 9.9. Market Attractiveness Analysis

10. Latin America Animal Stem Cell Therapy Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By Source
    • 10.2.4. By Application
    • 10.2.5. By Species
    • 10.2.6. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 10.4.1. Hemopoietic Stem Cells
    • 10.4.2. Mesenchymal Stem Cells
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2025-2032
    • 10.5.1. Allogeneic Animal Stem Cell Therapy
    • 10.5.2. Autologous Animal Stem Cell Therapy
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 10.6.1. Osteoarthritis
    • 10.6.2. Soft Tissue Injuries
    • 10.6.3. Traumatic Fractures
    • 10.6.4. Tendonitis
    • 10.6.5. Inflammatory Bowel Disease
    • 10.6.6. Others
  • 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 10.7.1. Canine
    • 10.7.2. Feline
    • 10.7.3. Equine
  • 10.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.8.1. Veterinary Hospitals
    • 10.8.2. Veterinary Clinics
    • 10.8.3. Veterinary Research Institutes
  • 10.9. Market Attractiveness Analysis

11. Middle East & Africa Animal Stem Cell Therapy Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product Type
    • 11.2.3. By Source
    • 11.2.4. By Application
    • 11.2.5. By Species
    • 11.2.6. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
    • 11.4.1. Hemopoietic Stem Cells
    • 11.4.2. Mesenchymal Stem Cells
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Source, 2025-2032
    • 11.5.1. Allogeneic Animal Stem Cell Therapy
    • 11.5.2. Autologous Animal Stem Cell Therapy
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 11.6.1. Osteoarthritis
    • 11.6.2. Soft Tissue Injuries
    • 11.6.3. Traumatic Fractures
    • 11.6.4. Tendonitis
    • 11.6.5. Inflammatory Bowel Disease
    • 11.6.6. Others
  • 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 11.7.1. Canine
    • 11.7.2. Feline
    • 11.7.3. Equine
  • 11.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.8.1. Veterinary Hospitals
    • 11.8.2. Veterinary Clinics
    • 11.8.3. Veterinary Research Institutes
  • 11.9. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Aratana Therapeutics, Inc.
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. VetStem, Inc.
    • 12.3.3. Magellan Stem Cells
    • 12.3.4. StemcellX
    • 12.3.5. Boehringer Ingelheim (Global stem cell technology)
    • 12.3.6. Cell Therapy Sciences
    • 12.3.7. VETherapy Corporation
    • 12.3.8. MediVet Biologics LLC (Ardent Animal Health)
    • 12.3.9. Medrego
    • 12.3.10. AniCell Biotech
    • 12.3.11. Gallant
    • 12.3.12. Companion Animal Health
    • 12.3.13. Kintaro Cells Power
    • 12.3.14. StemBioSys
    • 12.3.15. Regen BioPharma, Inc.
    • 12.3.16. Celltex Therapeutics Corporation
    • 12.3.17. Regenexx

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations